Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Arteriosclerosis, Thrombosis, and Vascular Biology|July 22, 1998
Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesionsM A Ramos, M Kuzuya, T Esaki, et al.
Atherosclerosis|November 24, 1999
Endothelium-dependent relaxation of rabbit atherosclerotic aorta was not restored by control of hyperlipidemia: the possible role of peroxynitrite (ONOO(-))T Hayashi, K Yamada, T Esaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1992
Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1M Kuroki, M Nakamura, Y Itoyama, et al.
Journal of Neurochemistry|December 26, 2001
Local and global cerebral blood flow and glucose utilization in the alpha-galactosidase A knockout mouse model of Fabry diseaseY Itoh, T Esaki, M Cook, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|November 1, 1994
[Detection of Mycoplasma genitalium from male patients with non-gonococcal urethritis by polymerase chain reaction]H Komeda, T Deguchi, M Yasuda, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery|September 14, 2001
[Delayed traumatic diaphragmatic hernia diagnosed by magnetic resonance imaging and direct coronal computed tomography: report of a case]B Shirasawa, S Furukawa, T Tsushimi, et al.
Endoscopy|February 7, 2004
Dieulafoy's lesion of the esophagus correctly diagnosed and successfully treated by the endoscopic injection of N-butyl-2-cyanoacrylateT Yoshida, K Adachi, Y Tanioka, et al.
British Journal of Cancer|September 19, 2013
Randomised phase II study of S-1/cisplatin plus TSU-68 vs S-1/cisplatin in patients with advanced gastric cancerW Koizumi, K Yamaguchi, H Hosaka, et al.
British Journal of Cancer|June 15, 2006
Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancerK Yamaguchi, T Shimamura, I Hyodo, et al.
ESMO Open|December 12, 2022
A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)W Okamoto, K Sakai, A Makiyama, et al.
Pageof 6